When Should Prophylactic Oophorectomy Be Recommended at the Time of Elective Hysterectomy?
Journal
Clinical obstetrics and gynecology
ISSN: 1532-5520
Titre abrégé: Clin Obstet Gynecol
Pays: United States
ID NLM: 0070014
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
pubmed:
27
12
2019
medline:
1
6
2021
entrez:
27
12
2019
Statut:
ppublish
Résumé
Gynecologists are frequently confronted with the decision of when to recommend oophorectomy at the time of an elective hysterectomy. When deciding if oophorectomy should be recommended, first a careful history and risk assessment must be performed to determine if a patient is a candidate for a risk-reducing oophorectomy. If the patient does not have a hereditary ovarian cancer risk, then it is recommended the surgeon carefully consider the implications of ovarian removal on the health of their patient. This review covers the potential benefits and risks of prophylactic oophorectomy and offers a decision aid for when to recommend this procedure.
Identifiants
pubmed: 31876638
doi: 10.1097/GRF.0000000000000521
pii: 00003081-202006000-00011
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-348Références
Murphy P, Phillips G, Hall A, et al. ACOG Women’s Health Stats & Facts; 2011. Available at: www.acog.org/-/media/NewsRoom/MediaKit.pdf. Accessed February 20, 2019.
National Center for Health Statistics. Number of all-listed procedures for discharges from short-stay hospitals: United States. CDC website; 2010. Available at: www.cdc.gov/nchs/data/nhds/10Detaileddiagnosesprocedures/2010det10_alllistedprocedures.pdf. Accessed June 1, 2013.
Labidi-Galy SI, Papp E, Hallberg D, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017;8:1093.
Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–226.
Karp NE, Fenner DE, Burgunder-Zdravkovski L, et al. Removal of normal ovaries in women under age 51 at the time of hysterectomy. Am J Obstet Gynecol. 2015;213:716.e1–716.e6.
Asante A, Whiteman MK, Kulkarni A, et al. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006. Obstet Gynecol. 2010;116:1088–1095.
Perera HK, Ananth CV, Richards CA, et al. Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol. 2013;121:717–726.
Escher M, Sappino AP. Primary care physicians’ knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol. 2000;11:1131–1135.
Mehnert A, Bergelt C, Koch U. Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer. Patient Educ Couns. 2003;49:183–188.
Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. National Cancer Institute. 2019. Available at: https://seer.cancer.gov/csr/1975_2014/. Accessed June 5, 2019.
Committee on Practice Bulletins–Gynecology, Committee on Genetics, Society of Gynecologic Oncology. Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome. Obstet Gynecol. 2017;130:e110–e126.
Zakhour M, Danovitch Y, Lester J, et al. Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers. Gynecol Oncol. 2016;143:231–235.
National Comprehensive Center Network (NCCN) Guidelines and Clinical Resources. National Comprehensive Cancer Network; 2019. Available at: www.nccn.org/professionals/physician_gls/default.aspx. Accessed March 13, 2019.
Manchanda R, Menon U. Setting the threshold for surgical prevention in women at increased risk of ovarian cancer. Int J Gynecol Cancer. 2018;28:34–42.
Stratton JF, Pharoah P, Smith SK, et al. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493–499.
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology, Genetic/Familial High-Risk Assessment: Breast and Ovarian; 2013. Available at: www.nccn.org. Accessed February 5, 2013.
Fast Stats: An Interactive Tool for Access to SEER Cancer Statistics. Surveillance Research Program. National Cancer Institute. 2019. Available at: https://seer.cancer.gov/statfacts/html/ovary.html. Accessed February 20, 2019.
Averette HE, Nguyen HN. The role of prophylactic oophorectomy in cancer prevention. Gynecol Oncol. 1994;55(pt 2):S38–S41.
Rauh-Hain JA, Krivak TC, Del Carmen M, et al. Ovarian cancer screening and early detection in the general population. Rev Obstet Gynecol. 2011;4:15–21.
Marchetti C, De Felice F, Palaia I, et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Womens Health. 2014;14:150.
Schairer C, Persson I, Falkeborn M, et al. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer. 1997;70:150–154.
Casiano ER, Trabuco EC, Bharucha AE, et al. Risk of oophorectomy after hysterectomy. Obstet Gynecol. 2013;121:1069–1074.
Lowder JL, Oliphant SS, Ghetti C, et al. Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004. Am J Obstet Gynecol. 2010;202:538.e1–538.e9.
Xu J, Murphy SL, Kochanek KD, et al. National Vital Statistics Reports: Deaths Final Data for 2013. Natl Vital Stat Rep. 2016;64:119.
Leading Causes of Death by Age Groups, All Females-United States; 2015. Available at: www.cdc.gov/women/lcod/2015/all-females/index.htm. Accessed March 6, 2019.
Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy versus ovarian conservation in the Nurses’ Health Study. Obstet Gynecol. 2013;121:709–716.
Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–1110.
Rocca WA, Grossardt BR, de Andrade M, et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7:821–828.
Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality following early bilateral oophorectomy. Menopause. 2009;16:15–23.
Rocca WA, Rocca LG, Smith CY, et al. Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA). BMJ Open. 2017;7:e018861.
Howard BV, Lewis K, Robert L, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy. Circulation. 2005;111:1462–1470.
Evans EC, Matteson KA, Orejuela FJ, et al. Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review. Obstet Gynecol. 2016;128:476–485.
Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative Randomized Controlled Trial. JAMA. 2004;291:1701–1712.
Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses’ Health Study. Obstet Gynecol. 2009;113:1027–1037.
Melton LJ, Khosla S, Malkasian GD, et al. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res. 2003;18:900–905.
Melton LJ, Crowson CS, Malkasian GD, et al. Fracture risk following bilateral oophorectomy. J Clin Epidemiol. 1996;49:1111–1115.
Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69:1074–1083.
Phung TKT, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord. 2010;30:43–50.
Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014;82:222–229.
Tucker PE, Bulsara MK, Salfinger SG, et al. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. Gynecol Oncol. 2016;140:95–100.
Shifren JL, Avis NE. Surgical menopause: effects on psychological well-being and sexuality. Menopause. 2007;14(pt 2):586–591.
Rocca WA, Grossardt BR, Geda YE, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause. 2008;15:1050–1059.
Stuursma A, van Driel CMG, Wessels NJ, et al. Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy. Maturitas. 2018;111:69–76.
Judd HL, Judd GE, Lucas WE, et al. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974;39:1020–1024.
Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31:161–169.
Walker JL, Powell CB, Chen L, et al. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer. 2015;121:2108–2120.
Cibula D, Widschwendter M, Májek O, et al. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update. 2011;17:55–67.
Birrer N, Chinchilla C, Del Carmen M, et al. Is hormone replacement therapy safe in women with a BRCA mutation? A systematic review of the contemporary literature. Am J Clin Oncol. 2018;41:313–315.